Maven Securities LTD Arcutis Biotherapeutics, Inc. Transaction History

Maven Securities LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$24.42 - $34.75 $2.85 Million - $4.06 Million	-116,728 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$24.47 - $36.98 $2.86 Million - $4.32 Million	116,728 New	116,728 $3.29 Million
Q4 2020 Feb 12, 2021	SELL	$17.82 - $31.73 $267,300 - $475,950	-15,000 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$23.44 - $32.28 $351,600 - $484,200	15,000 New	15,000 $433,000

193

127M

5.43M

257K

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $575M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.